Insider · CIK 0001838139
Marshall Urist
officer
Files at RPRX (Royalty Pharma plc). First filing Sep 30, 2026, latest Oct 5, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $474k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RPRX: Royalty Pharma plc
RPRXOct 9, 2026 · close 56.93
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Royalty Pharma plc | $236k 4,126 shares | -100% | +63% from low-11% from high | |
| 36Weak | Royalty Pharma plc | $239k 4,126 shares | -50% | +69% from low-9% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | RPRX Royalty Pharma plc | SOpen-market sale Class A Ordinary Shares10b5-1 | -4,126 | $57.10 | $236k | 0 | 7 d ago |
| Sep 28, 2026 | RPRX Royalty Pharma plc | SOpen-market sale Class A Ordinary Shares10b5-1 | -4,126 | $57.88 | $239k | 4,126 | 12 d ago |
| May 16, 2025 | RPRX Royalty Pharma plc | AGrant or award Class E Ordinary Sharesderivativeindirect: See Footnote (1)(2) | +1,356,528 | $0.00 | $0 | 1,356,528 | May 20, 2025 |
| May 8, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Shares | +36,484 | $0.00 | $0 | 83,151 | May 9, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.